What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

PUBLISHER: TechNavio | PRODUCT CODE: 1798109

PUBLISHER: TechNavio | PRODUCT CODE: 1798109

Global Allergy Rhinitis Drugs Market 2025-2029

PUBLISHED: August 19, 2025

PAGES: 220 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The allergy rhinitis drugs market is forecasted to grow by USD 4,385 mn during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the allergy rhinitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergy rhinitis, high unmet medical needs, and technological advances in allergy rhinitis diagnostics.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	4.3%
CAGR	4.6%
Incremental Value	$4,385 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's allergy rhinitis drugs market is segmented as below:

By Distribution Channel

Offline
Online

By Product

Antihistamines
Intranasal corticosteroids
Immunotherapies
Others

By Route Of Administration

Oral
Nasal
Injectable

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in research and development of new therapies as one of the prime reasons driving the allergy rhinitis drugs market growth during the next few years. Also, increasing demand for over-the-counter medicines and increase in collaborations among companies will lead to sizable demand in the market.

The report on the allergy rhinitis drugs market covers the following areas:

Allergy Rhinitis Drugs Market sizing
Allergy Rhinitis Drugs Market forecast
Allergy Rhinitis Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy rhinitis drugs market vendors that include ALK Abello AS, Apotex Inc., Bayer AG, Cadila Pharmaceuticals Ltd., Catalent Inc., DR Reddys Laboratories Ltd., Faes Farma, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., HAL Allergy BV, Haleon PLC, Hikma Pharmaceuticals PLC, Merck and Co. Inc., Mitsubishi Chemical Group Corp., Novartis AG, Sanofi SA, Stallergenes Greer Ltd., and Viatris Inc.. Also, the allergy rhinitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR41321

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Allergy Rhinitis Drugs Market 2019 - 2023
- Historic Market Size - Data Table on Global Allergy Rhinitis Drugs Market 2019 - 2023 ($ million)
5.2 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.3 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.4 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on Global Allergy Rhinitis Drugs Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Distribution Channel

8.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
8.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
8.3 Offline - Market size and forecast 2024-2029
- Chart on Offline - Market size and forecast 2024-2029 ($ million)
- Data Table on Offline - Market size and forecast 2024-2029 ($ million)
- Chart on Offline - Year-over-year growth 2024-2029 (%)
- Data Table on Offline - Year-over-year growth 2024-2029 (%)
8.4 Online - Market size and forecast 2024-2029
- Chart on Online - Market size and forecast 2024-2029 ($ million)
- Data Table on Online - Market size and forecast 2024-2029 ($ million)
- Chart on Online - Year-over-year growth 2024-2029 (%)
- Data Table on Online - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

9 Market Segmentation by Product

9.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
9.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
9.3 Antihistamines - Market size and forecast 2024-2029
- Chart on Antihistamines - Market size and forecast 2024-2029 ($ million)
- Data Table on Antihistamines - Market size and forecast 2024-2029 ($ million)
- Chart on Antihistamines - Year-over-year growth 2024-2029 (%)
- Data Table on Antihistamines - Year-over-year growth 2024-2029 (%)
9.4 Intranasal corticosteroids - Market size and forecast 2024-2029
- Chart on Intranasal corticosteroids - Market size and forecast 2024-2029 ($ million)
- Data Table on Intranasal corticosteroids - Market size and forecast 2024-2029 ($ million)
- Chart on Intranasal corticosteroids - Year-over-year growth 2024-2029 (%)
- Data Table on Intranasal corticosteroids - Year-over-year growth 2024-2029 (%)
9.5 Immunotherapies - Market size and forecast 2024-2029
- Chart on Immunotherapies - Market size and forecast 2024-2029 ($ million)
- Data Table on Immunotherapies - Market size and forecast 2024-2029 ($ million)
- Chart on Immunotherapies - Year-over-year growth 2024-2029 (%)
- Data Table on Immunotherapies - Year-over-year growth 2024-2029 (%)
9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

10 Market Segmentation by Route of Administration

10.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
10.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.4 Nasal - Market size and forecast 2024-2029
- Chart on Nasal - Market size and forecast 2024-2029 ($ million)
- Data Table on Nasal - Market size and forecast 2024-2029 ($ million)
- Chart on Nasal - Year-over-year growth 2024-2029 (%)
- Data Table on Nasal - Year-over-year growth 2024-2029 (%)
10.5 Injectable - Market size and forecast 2024-2029
- Chart on Injectable - Market size and forecast 2024-2029 ($ million)
- Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
- Chart on Injectable - Year-over-year growth 2024-2029 (%)
- Data Table on Injectable - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.11 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.12 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 ALK Abello AS
- ALK Abello AS - Overview
- ALK Abello AS - Product / Service
- ALK Abello AS - Key offerings
- SWOT
15.5 Apotex Inc.
- Apotex Inc. - Overview
- Apotex Inc. - Product / Service
- Apotex Inc. - Key news
- Apotex Inc. - Key offerings
- SWOT
15.6 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.7 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
15.8 Faes Farma
- Faes Farma - Overview
- Faes Farma - Product / Service
- Faes Farma - Key offerings
- SWOT
15.9 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
15.10 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
15.11 Haleon Plc
- Haleon Plc - Overview
- Haleon Plc - Business segments
- Haleon Plc - Key offerings
- Haleon Plc - Segment focus
- SWOT
15.12 Hikma Pharmaceuticals Plc
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- SWOT
15.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
15.14 Mitsubishi Chemical Group Corp.
- Mitsubishi Chemical Group Corp. - Overview
- Mitsubishi Chemical Group Corp. - Business segments
- Mitsubishi Chemical Group Corp. - Key news
- Mitsubishi Chemical Group Corp. - Key offerings
- Mitsubishi Chemical Group Corp. - Segment focus
- SWOT
15.15 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
15.17 Stallergenes Greer Ltd.
- Stallergenes Greer Ltd. - Overview
- Stallergenes Greer Ltd. - Product / Service
- Stallergenes Greer Ltd. - Key offerings
- SWOT
15.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR41321

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Allergy Rhinitis Drugs Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits39: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Distribution Channel
Exhibits41: Data Table on Comparison by Distribution Channel
Exhibits42: Chart on Offline - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Offline - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Offline - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Offline - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Online - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Online - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Online - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Online - Year-over-year growth 2024-2029 (%)
Exhibits50: Market opportunity by Distribution Channel ($ million)
Exhibits51: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits52: Chart on Product - Market share 2024-2029 (%)
Exhibits53: Data Table on Product - Market share 2024-2029 (%)
Exhibits54: Chart on Comparison by Product
Exhibits55: Data Table on Comparison by Product
Exhibits56: Chart on Antihistamines - Market size and forecast 2024-2029 ($ million)
Exhibits57: Data Table on Antihistamines - Market size and forecast 2024-2029 ($ million)
Exhibits58: Chart on Antihistamines - Year-over-year growth 2024-2029 (%)
Exhibits59: Data Table on Antihistamines - Year-over-year growth 2024-2029 (%)
Exhibits60: Chart on Intranasal corticosteroids - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Intranasal corticosteroids - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Intranasal corticosteroids - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Intranasal corticosteroids - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Immunotherapies - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Immunotherapies - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Immunotherapies - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Immunotherapies - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits72: Market opportunity by Product ($ million)
Exhibits73: Data Table on Market opportunity by Product ($ million)
Exhibits74: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits75: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits76: Chart on Comparison by Route of Administration
Exhibits77: Data Table on Comparison by Route of Administration
Exhibits78: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on Nasal - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Nasal - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Nasal - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Nasal - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits90: Market opportunity by Route of Administration ($ million)
Exhibits91: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits95: Chart on Geographic comparison
Exhibits96: Data Table on Geographic comparison
Exhibits97: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits153: Market opportunity By Geographical Landscape ($ million)
Exhibits154: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits155: Impact of drivers and challenges in 2024 and 2029
Exhibits156: Overview on criticality of inputs and factors of differentiation
Exhibits157: Overview on factors of disruption
Exhibits158: Impact of key risks on business
Exhibits159: Companies covered
Exhibits160: Company ranking index
Exhibits161: Matrix on companies position and classification
Exhibits162: ALK Abello AS - Overview
Exhibits163: ALK Abello AS - Product / Service
Exhibits164: ALK Abello AS - Key offerings
Exhibits165: SWOT
Exhibits166: Apotex Inc. - Overview
Exhibits167: Apotex Inc. - Product / Service
Exhibits168: Apotex Inc. - Key news
Exhibits169: Apotex Inc. - Key offerings
Exhibits170: SWOT
Exhibits171: Bayer AG - Overview
Exhibits172: Bayer AG - Business segments
Exhibits173: Bayer AG - Key news
Exhibits174: Bayer AG - Key offerings
Exhibits175: Bayer AG - Segment focus
Exhibits176: SWOT
Exhibits177: Dr Reddys Laboratories Ltd. - Overview
Exhibits178: Dr Reddys Laboratories Ltd. - Business segments
Exhibits179: Dr Reddys Laboratories Ltd. - Key news
Exhibits180: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits181: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits182: SWOT
Exhibits183: Faes Farma - Overview
Exhibits184: Faes Farma - Product / Service
Exhibits185: Faes Farma - Key offerings
Exhibits186: SWOT
Exhibits187: GlaxoSmithKline Plc - Overview
Exhibits188: GlaxoSmithKline Plc - Business segments
Exhibits189: GlaxoSmithKline Plc - Key news
Exhibits190: GlaxoSmithKline Plc - Key offerings
Exhibits191: GlaxoSmithKline Plc - Segment focus
Exhibits192: SWOT
Exhibits193: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits194: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits195: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits196: SWOT
Exhibits197: Haleon Plc - Overview
Exhibits198: Haleon Plc - Business segments
Exhibits199: Haleon Plc - Key offerings
Exhibits200: Haleon Plc - Segment focus
Exhibits201: SWOT
Exhibits202: Hikma Pharmaceuticals Plc - Overview
Exhibits203: Hikma Pharmaceuticals Plc - Business segments
Exhibits204: Hikma Pharmaceuticals Plc - Key news
Exhibits205: Hikma Pharmaceuticals Plc - Key offerings
Exhibits206: Hikma Pharmaceuticals Plc - Segment focus
Exhibits207: SWOT
Exhibits208: Merck and Co. Inc. - Overview
Exhibits209: Merck and Co. Inc. - Business segments
Exhibits210: Merck and Co. Inc. - Key news
Exhibits211: Merck and Co. Inc. - Key offerings
Exhibits212: Merck and Co. Inc. - Segment focus
Exhibits213: SWOT
Exhibits214: Mitsubishi Chemical Group Corp. - Overview
Exhibits215: Mitsubishi Chemical Group Corp. - Business segments
Exhibits216: Mitsubishi Chemical Group Corp. - Key news
Exhibits217: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits218: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits219: SWOT
Exhibits220: Novartis AG - Overview
Exhibits221: Novartis AG - Business segments
Exhibits222: Novartis AG - Key news
Exhibits223: Novartis AG - Key offerings
Exhibits224: Novartis AG - Segment focus
Exhibits225: SWOT
Exhibits226: Sanofi SA - Overview
Exhibits227: Sanofi SA - Business segments
Exhibits228: Sanofi SA - Key news
Exhibits229: Sanofi SA - Key offerings
Exhibits230: Sanofi SA - Segment focus
Exhibits231: SWOT
Exhibits232: Stallergenes Greer Ltd. - Overview
Exhibits233: Stallergenes Greer Ltd. - Product / Service
Exhibits234: Stallergenes Greer Ltd. - Key offerings
Exhibits235: SWOT
Exhibits236: Viatris Inc. - Overview
Exhibits237: Viatris Inc. - Business segments
Exhibits238: Viatris Inc. - Key news
Exhibits239: Viatris Inc. - Key offerings
Exhibits240: Viatris Inc. - Segment focus
Exhibits241: SWOT
Exhibits242: Inclusions checklist
Exhibits243: Exclusions checklist
Exhibits244: Currency conversion rates for US$
Exhibits245: Research methodology
Exhibits246: Information sources
Exhibits247: Data validation
Exhibits248: Validation techniques employed for market sizing
Exhibits249: Data synthesis
Exhibits250: 360 degree market analysis
Exhibits251: List of abbreviations